A network meta-analysis of 23 randomized controlled trials (n = 5151 type 1 diabetes patients) showed a decrease in body weight of 5.1 kg in the insulin + exenatide group compared with the insulin group [40]. The gene discussed is INS; the disease is type 1 diabetes mellitus.